TCM Biotech International (4169.TW) Earnings Analysis
TCM Biotech International (4169.TW) has no confirmed upcoming earnings date. Last quarter (2024-12-31) it missed with EPS 0.1888 TWD vs 0.4 TWD est (-52.8%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E 859.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4169.TW next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4169.TW. This page updates as the calendar is published.
4169.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | 0.1888 TWD | 0.4 TWD | -52.8% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
4169.TW valuation and analyst view
| Trailing P/E | 859.38 |
|---|---|
| Trailing EPS | 0.32465 TWD |
| Price / book | 15.39 |
| Dividend yield | 0.12% |
| Market cap | 18.27B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is TCM Biotech International (4169.TW)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4169.TW. This page updates as the calendar is published.
Did 4169.TW beat earnings last quarter?
In its 2024-12-31 report, 4169.TW posted EPS of 0.1888 TWD versus a 0.4 TWD estimate — a miss of 52.8%.
What is 4169.TW's earnings track record?
Over the last 1 reported quarters with consensus data, 4169.TW beat estimates 0 times (0%).
What is 4169.TW's current P/E ratio and EPS?
4169.TW trades at a trailing P/E of 859.38 on trailing EPS of 0.3246456332876086 TWD.
What do analysts rate 4169.TW?
4169.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.